These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 9856847)
1. Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior. Büttner C; Henz BM; Welker P; Sepp NT; Grabbe J J Invest Dermatol; 1998 Dec; 111(6):1227-31. PubMed ID: 9856847 [TBL] [Abstract][Full Text] [Related]
2. Demonstration that mast cells, T cells, and B cells bearing the activating kit mutation D816V occur in clusters within the marrow of patients with mastocytosis. Taylor ML; Sehgal D; Raffeld M; Obiakor H; Akin C; Mage RG; Metcalfe DD J Mol Diagn; 2004 Nov; 6(4):335-42. PubMed ID: 15507672 [TBL] [Abstract][Full Text] [Related]
3. c-kit Mutations in patients with childhood-onset mastocytosis and genotype-phenotype correlation. Yanagihori H; Oyama N; Nakamura K; Kaneko F J Mol Diagn; 2005 May; 7(2):252-7. PubMed ID: 15858149 [TBL] [Abstract][Full Text] [Related]
4. Comparison of lesional skin c-KIT mutations with clinical phenotype in patients with mastocytosis. Chan IJ; Tharp MD Clin Exp Dermatol; 2018 Jun; 43(4):416-422. PubMed ID: 29350409 [TBL] [Abstract][Full Text] [Related]
5. Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Longley BJ; Tyrrell L; Lu SZ; Ma YS; Langley K; Ding TG; Duffy T; Jacobs P; Tang LH; Modlin I Nat Genet; 1996 Mar; 12(3):312-4. PubMed ID: 8589724 [TBL] [Abstract][Full Text] [Related]
6. Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations. Bodemer C; Hermine O; Palmérini F; Yang Y; Grandpeix-Guyodo C; Leventhal PS; Hadj-Rabia S; Nasca L; Georgin-Lavialle S; Cohen-Akenine A; Launay JM; Barete S; Feger F; Arock M; Catteau B; Sans B; Stalder JF; Skowron F; Thomas L; Lorette G; Plantin P; Bordigoni P; Lortholary O; de Prost Y; Moussy A; Sobol H; Dubreuil P J Invest Dermatol; 2010 Mar; 130(3):804-15. PubMed ID: 19865100 [TBL] [Abstract][Full Text] [Related]
7. Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. Longley BJ; Metcalfe DD; Tharp M; Wang X; Tyrrell L; Lu SZ; Heitjan D; Ma Y Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1609-14. PubMed ID: 9990072 [TBL] [Abstract][Full Text] [Related]
9. Association of paediatric mastocytosis with a polymorphism resulting in an amino acid substitution (M541L) in the transmembrane domain of c-KIT. Foster R; Byrnes E; Meldrum C; Griffith R; Ross G; Upjohn E; Braue A; Scott R; Varigos G; Ferrao P; Ashman LK Br J Dermatol; 2008 Nov; 159(5):1160-9. PubMed ID: 18795925 [TBL] [Abstract][Full Text] [Related]
10. Identification of KIT activating mutations in paediatric solitary mastocytoma. Ma D; Stence AA; Bossler AB; Hackman JR; Bellizzi AM Histopathology; 2014 Jan; 64(2):218-25. PubMed ID: 24128084 [TBL] [Abstract][Full Text] [Related]
11. Mastocytosis: state of the art. Horny HP; Sotlar K; Valent P Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883 [TBL] [Abstract][Full Text] [Related]
12. Mastocytosis in mice expressing human Kit receptor with the activating Asp816Val mutation. Zappulla JP; Dubreuil P; Desbois S; Létard S; Hamouda NB; Daëron M; Delsol G; Arock M; Liblau RS J Exp Med; 2005 Dec; 202(12):1635-41. PubMed ID: 16352739 [TBL] [Abstract][Full Text] [Related]
13. Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis. Akin C; Kirshenbaum AS; Semere T; Worobec AS; Scott LM; Metcalfe DD Exp Hematol; 2000 Feb; 28(2):140-7. PubMed ID: 10706069 [TBL] [Abstract][Full Text] [Related]
14. [Therapeutically relevant mutations in the receptor tyrosine kinase KIT in mastocytosis]. Sotlar K Verh Dtsch Ges Pathol; 2007; 91():169-76. PubMed ID: 18314612 [TBL] [Abstract][Full Text] [Related]
16. Mutation analysis of C-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis. Fritsche-Polanz R; Jordan JH; Feix A; Sperr WR; Sunder-Plassmann G; Valent P; Födinger M Br J Haematol; 2001 May; 113(2):357-64. PubMed ID: 11380399 [TBL] [Abstract][Full Text] [Related]
17. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Nagata H; Worobec AS; Oh CK; Chowdhury BA; Tannenbaum S; Suzuki Y; Metcalfe DD Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10560-4. PubMed ID: 7479840 [TBL] [Abstract][Full Text] [Related]
18. Molecular diagnosis of mast cell disorders: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology. Akin C J Mol Diagn; 2006 Sep; 8(4):412-9. PubMed ID: 16931579 [TBL] [Abstract][Full Text] [Related]
19. Recent advances in the understanding of mastocytosis: the role of KIT mutations. Orfao A; Garcia-Montero AC; Sanchez L; Escribano L; Br J Haematol; 2007 Jul; 138(1):12-30. PubMed ID: 17555444 [TBL] [Abstract][Full Text] [Related]